Our top pick for
Building a portfolio
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Synlogic stock
Own Synlogic stock in just a few minutes.
Synlogic, Inc is a biotechnology business based in the US. Synlogic shares (SYBX) are listed on the NASDAQ and all prices are listed in US Dollars. Synlogic employs 72 staff and has a trailing 12-month revenue of around USD$545,000.
How to buy shares in Synlogic
- Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
- Search for Synlogic. Find the stock by name or ticker symbol: SYBX. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Synlogic reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Synlogic, depending on your broker.
- Check in on your investment. Congratulations, you own a part of Synlogic. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
Synlogic share price
Use our graph to track the performance of SYBX stocks over time.Synlogic shares at a glance
Information last updated 2021-04-09.
| 52-week range | USD$1.74 - USD$5.11 |
|---|---|
| 50-day moving average | USD$3.8224 |
| 200-day moving average | USD$2.9072 |
| Wall St. target price | USD$10.71 |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | USD$-1.861 |
Buy Synlogic shares from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Synlogic stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Synlogic financials
| Revenue TTM | USD$545,000 |
|---|---|
| Gross profit TTM | USD$545,000 |
| Return on assets TTM | -22.74% |
| Return on equity TTM | -43.5% |
| Profit margin | 0% |
| Book value | $3.015 |
| Market capitalisation | USD$132.5 million |
TTM: trailing 12 months
Shorting Synlogic shares
There are currently 355,086 Synlogic shares held short by investors – that's known as Synlogic's "short interest". This figure is 11% up from 319,823 last month.
There are a few different ways that this level of interest in shorting Synlogic shares can be evaluated.
Synlogic's "short interest ratio" (SIR)
Synlogic's "short interest ratio" (SIR) is the quantity of Synlogic shares currently shorted divided by the average quantity of Synlogic shares traded daily (recently around 288687.80487805). Synlogic's SIR currently stands at 1.23. In other words for every 100,000 Synlogic shares traded daily on the market, roughly 1230 shares are currently held short.
However Synlogic's short interest can also be evaluated against the total number of Synlogic shares, or, against the total number of tradable Synlogic shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Synlogic's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Synlogic shares in existence, roughly 10 shares are currently held short) or 0.0152% of the tradable shares (for every 100,000 tradable Synlogic shares, roughly 15 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Synlogic.
Find out more about how you can short Synlogic stock.
Synlogic share dividends
We're not expecting Synlogic to pay a dividend over the next 12 months.
Have Synlogic's shares ever split?
Synlogic's shares were split on a 1:7 basis on 27 August 2017. So if you had owned 7 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Synlogic shares – just the quantity. However, indirectly, the new 600% higher share price could have impacted the market appetite for Synlogic shares which in turn could have impacted Synlogic's share price.
Synlogic share price volatility
Over the last 12 months, Synlogic's shares have ranged in value from as little as $1.74 up to $5.11. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Synlogic's is 1.7905. This would suggest that Synlogic's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Synlogic overview
Synlogic, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of synthetic biotic medicines to treat metabolic, inflammatory, and cancer diseases in the United States. Its therapeutic programs include SYNB1618, an oral therapy that is in Phase II clinical trial to treat phenylketonuria (PKU), as well as pre-clinical stage product SYNB1934 for the treatment of PKU; and SYNB8802 that is in Phase I clinical trial for the treatment of Enteric Hyperoxaluria. The company is also developing SYNB1891, an intratumorally administered synthetic biotic medicine that is in Phase I clinical trial to treat solid tumors and lymphoma. It has a collaboration agreement with Ginkgo Bioworks for the development of synthetic biotic medicines. Synlogic, Inc. is headquartered in Cambridge, Massachusetts.
Frequently asked questions
More guides on Finder
-
How to buy PrimeEnergy Resources Corporation stock
Steps to owning and managing PNRG, with 24-hour and historical pricing before you buy.
-
How to buy Premier stock
Steps to owning and managing PINC, with 24-hour and historical pricing before you buy.
-
How to buy Predictive Oncology stock
Steps to owning and managing POAI, with 24-hour and historical pricing before you buy.
-
How to buy Powerbridge Technologies CoLtd stock
Steps to owning and managing PBTS, with 24-hour and historical pricing before you buy.
-
How to buy Portman Ridge Finance Corporation stock
Steps to owning and managing PTMN, with 24-hour and historical pricing before you buy.
-
How to buy Popular stock
Steps to owning and managing BPOP, with 24-hour and historical pricing before you buy.
-
How to buy Playa Hotels-and-Resorts N-V stock
Steps to owning and managing PLYA, with 24-hour and historical pricing before you buy.
-
How to buy Plains GP Holdings L-P stock
Steps to owning and managing PAGP, with 24-hour and historical pricing before you buy.
-
How to buy Plains All American Pipeline L-P stock
Steps to owning and managing PAA, with 24-hour and historical pricing before you buy.
-
How to buy Property Solutions Acquisition stock
Steps to owning and managing PSACU, with 24-hour and historical pricing before you buy.
Ask an Expert